Davis R M Inc. Has $22.61 Million Stock Position in Intuitive Surgical, Inc. $ISRG

Davis R M Inc. grew its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 607.8% in the second quarter, Holdings Channel.com reports. The fund owned 41,614 shares of the medical equipment provider’s stock after buying an additional 35,735 shares during the period. Davis R M Inc.’s holdings in Intuitive Surgical were worth $22,614,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also modified their holdings of ISRG. Aaron Wealth Advisors LLC boosted its stake in Intuitive Surgical by 0.8% during the second quarter. Aaron Wealth Advisors LLC now owns 2,528 shares of the medical equipment provider’s stock worth $1,374,000 after buying an additional 19 shares in the last quarter. J. W. Coons Advisors LLC lifted its holdings in shares of Intuitive Surgical by 1.4% during the 1st quarter. J. W. Coons Advisors LLC now owns 1,497 shares of the medical equipment provider’s stock worth $741,000 after acquiring an additional 20 shares during the period. Exencial Wealth Advisors LLC lifted its holdings in shares of Intuitive Surgical by 3.1% during the 1st quarter. Exencial Wealth Advisors LLC now owns 661 shares of the medical equipment provider’s stock worth $327,000 after acquiring an additional 20 shares during the period. Evergreen Capital Management LLC boosted its position in shares of Intuitive Surgical by 0.5% during the 1st quarter. Evergreen Capital Management LLC now owns 4,288 shares of the medical equipment provider’s stock valued at $2,124,000 after acquiring an additional 20 shares in the last quarter. Finally, Rise Advisors LLC increased its stake in Intuitive Surgical by 5.6% in the first quarter. Rise Advisors LLC now owns 378 shares of the medical equipment provider’s stock valued at $187,000 after acquiring an additional 20 shares during the period. 83.64% of the stock is currently owned by institutional investors.

Intuitive Surgical Stock Performance

Shares of ISRG opened at $560.00 on Monday. The stock has a fifty day moving average price of $471.89 and a two-hundred day moving average price of $501.11. Intuitive Surgical, Inc. has a 52-week low of $425.00 and a 52-week high of $616.00. The company has a market cap of $200.75 billion, a price-to-earnings ratio of 74.07, a PEG ratio of 4.94 and a beta of 1.62.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 EPS for the quarter, topping the consensus estimate of $1.99 by $0.41. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The company had revenue of $2.51 billion for the quarter, compared to analysts’ expectations of $2.41 billion. During the same quarter in the prior year, the business earned $1.84 earnings per share. The business’s revenue for the quarter was up 22.9% on a year-over-year basis. As a group, research analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Insider Activity

In other Intuitive Surgical news, Director Craig H. Barratt sold 2,193 shares of the firm’s stock in a transaction dated Friday, October 24th. The shares were sold at an average price of $548.01, for a total value of $1,201,785.93. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, VP Fredrik Widman sold 2,067 shares of the business’s stock in a transaction dated Wednesday, November 5th. The stock was sold at an average price of $550.00, for a total transaction of $1,136,850.00. Following the completion of the transaction, the vice president directly owned 473 shares of the company’s stock, valued at approximately $260,150. This represents a 81.38% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders have sold 98,078 shares of company stock worth $51,445,892. 0.70% of the stock is currently owned by insiders.

Analyst Ratings Changes

A number of research analysts have commented on the stock. Sanford C. Bernstein restated an “outperform” rating and set a $685.00 price target on shares of Intuitive Surgical in a research note on Tuesday, October 21st. Royal Bank Of Canada set a $625.00 target price on Intuitive Surgical and gave the stock an “outperform” rating in a research report on Wednesday, October 22nd. Deutsche Bank Aktiengesellschaft reaffirmed a “sell” rating on shares of Intuitive Surgical in a research note on Friday, August 22nd. HSBC increased their price objective on Intuitive Surgical from $595.00 to $644.00 and gave the stock a “buy” rating in a research note on Thursday, October 23rd. Finally, Piper Sandler lifted their price objective on Intuitive Surgical from $595.00 to $610.00 and gave the company an “overweight” rating in a report on Wednesday, October 22nd. Two investment analysts have rated the stock with a Strong Buy rating, nineteen have issued a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, Intuitive Surgical has an average rating of “Moderate Buy” and an average price target of $608.92.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.